Related Experiment Video

Updated: Nov 22, 2025

The Use of Mouse Mammary Tumor Cells in an In Vitro Invasion Assay as a Measure of Oncogenic Cell Behavior
08:12

The Use of Mouse Mammary Tumor Cells in an In Vitro Invasion Assay as a Measure of Oncogenic Cell Behavior

Published on: June 12, 2019

5.3K

The multiple regulation of metastasis suppressor NM23-H1 in cancer

Liting Yu1, Xindong Wang1, Wanheng Zhang2

  • 1School of Life Science and Technology, China Pharmaceutical University, Nanjing, PR China.

Life Sciences
|January 9, 2021
PubMed

Insights

NM23-H1, a key protein in cancer metastasis, has a dual role as both a suppressor and promoter. Understanding its complex regulation is crucial for developing effective anti-metastatic cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Metastasis is a primary cause of cancer mortality.
  • NM23-H1 was the first identified metastasis suppressor, showing therapeutic potential.
  • NM23-H1 exhibits a complex, dichotomous role in tumor metastasis (suppressor vs. promoter).

Purpose of the Study:

  • To review the multifaceted regulatory mechanisms governing NM23-H1 in cancer.
  • To elucidate how these mechanisms influence NM23-H1's anti-metastatic function.
  • To address challenges in the clinical application of NM23-H1 as a therapeutic target.

Main Methods:

  • Literature review of studies on NM23-H1 in cancer.
  • Analysis of NM23-H1's biochemical activities (NDPK, HPK, exonuclease, scaffold).
  • Examination of cellular regulation of NM23-H1 (transcription, localization, activity, degradation).

Main Results:

  • NM23-H1's function is modulated by its diverse biochemical properties.
  • Tumor cells employ various strategies to regulate NM23-H1 expression and activity.
  • Mechanisms include transcriptional control, subcellular localization, enzymatic activity modulation, and protein degradation.

Conclusions:

  • The complex regulation of NM23-H1 significantly impacts its anti-metastatic efficacy.
  • Targeting NM23-H1 for cancer therapy requires a deep understanding of its regulatory network.
  • Further research into NM23-H1 regulation is essential for overcoming clinical challenges.
Keywords:
Anti-metastasisMultiple regulationNM23-H1Therapeutic intervention

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.8K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

17.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.1K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
32.5K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K